DAFTAR PUSTAKA

1. Centers for Disease Control and Prevention. Recommendations for the

identification of chronic hepatitis C virus infection among persons born
during 1945-1965. MMWR Recomm Rep. 2012 Aug 17. 61:1-32.

2. McCombs J, Matsuda T, Tonnu-Mihara I, et al. The risk of long-term

morbidity and mortality in patients with chronic hepatitis C: results from an
analysis of data from a Department of Veterans Affairs Clinical Registry.
JAMA Intern Med. 2014 Feb 1. 174(2):204-12.

3. Konsensus FKUI-PPHI tentang penatalaksanaan hepatitis C kronik tahun

2003.

4. Gani R.A., 2009. Hepatitis C. In: Buku Ajar Ilmu Penyakit Dalam. Jilid I.
Jakarta: Internal Publishing pp. 662-7

5. Galbraith JW, Morgan J, Rodgers J, et al. High yield and feasibility of baby
boomer birth cohort HCV screening in two urban, academic emergency
departments [abstract 59]. Presented at: International Conference on Viral
Hepatitis (ICVH); March 17-18, 2014; New York, NY

6. Thomas DL. Hepatitis C Virus. In: Oxford Textbook of Medicine 4th Edition.
Editors: Warrel DA, Cox TM, Firth JD, Benz AJ. Oxford Press. United State;
2003

7. World Gastroenterology Organisation Global Guidelines, Diagnosis,

Management and Prevention Of Hepatitis C, April 2013.

8. Pawlotsky Jean-Michel dkk. EASL Recommendations on Treatment of

Hepatitis C 2014, April 2014.

9. Ghany, MG. Strader, BD. Thomas, DL dan Seeff LB. Diagnosis,

Management, and Treatment of Hepatitis C. Hepatologi 2009:49)(4): 1335-
1374

10. Rischitelli G, Harris J, McCauley L, Gershon R, Guidotti T. The risk of

acquiring hepatitis B or C among public safety workers: a systematic review.
Am J Prev Med. 2001 May. 20(4):299-306.

11. Dienstag JL, Isselbacer KJ. Acute Viral Hepatitis. In Harrisons Principles of
Internal Medicine 16th Edition. Editors: Kasper DL, Braunwald E, Anthpny F,
Hauser S, Longo D, Jameson JL. McGraw-Hill Professional. London; 2004.
12. Mauss, Berg, Rockstroh, dkk. Hepatology A Clinical Textbook. Edition 2013.

13. Dervis E, Serez K. The prevalence of dermatologic manifestations related to

chronic hepatitis C virus infection in a study from a single center in Turkey.
Acta Dermatovenerol Alp Panonica Adriat. 2005 Sep. 14(3):93-8.

14. European Association for the Study of the Liver. 2011. EASL Clinical
Practice Guidelines: Management of Hepatitis C Virus Infection. Journal of
Hepatology. Vol. 55: 245-64.

15. Maticic M. Lichen planus in hepatitis C virus infection: an early marker that
may save lives. Acta Dermatovenerol Alp Panonica Adriat. 2007 Mar.
16(1):3-6.

16. Ngo-Metzger Q, Ward JW, Valdiserri RO. Expanded hepatitis C virus

screening recommendations promote opportunities for care and cure. Ann
Intern Med. 2013 Sep 3. 159(5):364-5.

17. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N. Accuracy of rapid

and point-of-care screening tests for hepatitis C: a systematic review and
meta-analysis. Ann Intern Med. 2012 Oct 16. 157(8):558-66.

18. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts

hepatitis C treatment-induced viral clearance. Nature. 2009 Sep 17.
461(7262):399-401.

19. Tong MJ, Reddy KR, Lee WM, et al. Treatment of chronic hepatitis C with
consensus interferon: a multicenter, randomized, controlled trial. Consensus
Interferon Study Group. Hepatology. 1997 Sep. 26(3):747-54.

20. Pineda JA, Caruz A, Rivero A, et al. Prediction of response to pegylated

interferon plus ribavirin by IL28B gene variation in patients coinfected with
HIV and hepatitis C virus. Clin Infect Dis. 2010 Oct 1. 51(7):788-95

21. Sulkowski MS, Naggie S, Lalezari J, et al. Sofosbuvir and ribavirin for
hepatitis C in patients with HIV coinfection. JAMA. 2014 Jul 23-30.
312(4):353-61.

22. Jezequel C, Bardou-Jacquet E, Desille Y, et al. Survival of patients infected

by chronic hepatitis C and F0F1 fibrosis at baseline after a 15 year follow-up.
Presented at: 50th Annual Meeting of the European Association for the Study
of the Liver (EASL); April 22-26, 2015; Vienna, Austria.
23. Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before,
during and after antiviral therapy of chronic hepatitis C: Results from the
Virahep-C study. J Hepatol. 2012 Nov. 57(5):946-52.

24. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr

Gastroenterol Rep. 2006 Feb. 8(1):53-9.

25. Seeff LB, Miller RN, Rabkin CS, et al. 45-year follow-up of hepatitis C virus
infection in healthy young adults. Ann Intern Med. 2000 Jan 18. 132(2):105-
11

26. Mira JA, Rivero-Juarez A, Lopez-Cortes LF, et al. Benefits from sustained
virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C
virus-coinfected patients with compensated cirrhosis. Clin Infect Dis. 2013
Jun. 56(11):1646-53